Related content

The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease

By Sun Yan-Ming   Wang Lan-Feng   Li Jia   Li Zhu-Qin   Pan Wei  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 157-161

Springer Publishing Company

Access to resources Recommend Favorite

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

By Lee Hon-Kit   Hu Miao   Lui Sandra SH   Ho Chung-Shun   Wong Chun-Kwok   Tomlinson Brian  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1283-1294

Future Medicine

Access to resources Recommend Favorite

Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients

By Miura Masatomo   Satoh Shigeru   Kagaya Hideaki   Saito Mitsuru   Numakura Kazuyuki   Tsuchiya Norihiko   Habuchi Tomonori  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 977-984

Future Medicine

Access to resources Recommend Favorite

Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors

By Molden Espen  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 587-596

Adis International

Access to resources Recommend Favorite

Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia

By Koter Maria   Franiak Ida   Broncel Marlena   Chojnowska-Jezierska Julita  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 5, 2003-05 ,pp. : 485-492

NRC Research Press

Access to resources Recommend Favorite